134 related articles for article (PubMed ID: 12820451)
1. A trial of single photon emission computed tomography of the liver with technetium-99m tetrofosmin to detect hepatocellular carcinoma.
Ho YJ; Jeng LB; Yang MD; Kao CH; Lin CC; Lee CC
Anticancer Res; 2003; 23(2C):1743-6. PubMed ID: 12820451
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report.
Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A
Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of technetium-99m methoxyisobutylisonitrile liver single photon emission computed tomography to detect hepatocellular carcinoma.
Ho YJ; Jen LB; Yang MD; Kao CH; Lin CC; Lee CC
Neoplasma; 2003; 50(2):117-9. PubMed ID: 12740645
[TBL] [Abstract][Full Text] [Related]
4. Detection of cervical lymph node metastases of nasopharyngeal carcinomas with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Anticancer Res; 2001; 21(1B):723-6. PubMed ID: 11299833
[TBL] [Abstract][Full Text] [Related]
5. Detection of cervical lymph node metastases in nasopharyngeal carcinomas: comparison with technetium-99m tetrofosmin single photon emission computed tomography and with magnetic resonance imaging.
Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH
Anticancer Res; 2003; 23(1B):719-22. PubMed ID: 12680173
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression.
Chang CS; Yang SS; Yeh HZ; Kao CH; Chen GH
Hepatogastroenterology; 2004; 51(55):211-4. PubMed ID: 15011866
[TBL] [Abstract][Full Text] [Related]
7. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m tetrofosmin single photon emission computed tomography to detect metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Wu HS; Liu FY; Huang WS; Liu YC; Chang CT; Kao CH
Clin Radiol; 2003 Oct; 58(10):787-90. PubMed ID: 14521888
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m tetrofosmin SPECT predicts chemotherapy response in small cell lung cancer.
Yeh JJ; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Tumour Biol; 2003; 24(3):151-5. PubMed ID: 14610319
[TBL] [Abstract][Full Text] [Related]
10. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
[TBL] [Abstract][Full Text] [Related]
11. Detection of esophageal carcinoma using single photon emission computed tomography with technetium-99m tetrofosmin.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(5C):3641-5. PubMed ID: 11268432
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of
Zheng J; Miao W; Huang C; Lin H
Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma: technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study.
Fukumoto M; Yoshida D; Hayase N; Kurohara A; Akagi N; Yoshida S
Cancer; 1999 Oct; 86(8):1470-9. PubMed ID: 10526275
[TBL] [Abstract][Full Text] [Related]
14. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.
Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A
Lung; 2003; 181(2):103-11. PubMed ID: 12953149
[TBL] [Abstract][Full Text] [Related]
15. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
[TBL] [Abstract][Full Text] [Related]
16. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
17. Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma.
Kim YS; Cho SW; Lee KJ; Hahm KB; Wang HJ; Yim H; Jin YM; Park CH
Clin Nucl Med; 1999 Nov; 24(11):874-9. PubMed ID: 10551471
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between 99m Tc-tetrofosmin uptake and P-glycoprotein expression in non-small-cell lung cancer].
Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
Rev Esp Med Nucl; 1998; 17(6):427-34. PubMed ID: 9873130
[TBL] [Abstract][Full Text] [Related]
19. Detection of recurrent or residual nasopharyngeal carcinomas after radiotherapy with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography--a preliminary study.
Tai CJ; Shiau YC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Invest; 2003; 21(4):536-41. PubMed ID: 14533443
[TBL] [Abstract][Full Text] [Related]
20. Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Mar; 56(3):333-8. PubMed ID: 25655623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
